VMLogix, meanwhile, is announcing that its LabManager product is now certified to run on Citrix XenServer.
Citrix acquired XenSource in 2007 for $500 million. Read more here.The LabManager product allows users to streamline the software development and testing process within virtual environments. In addition to XenServer, LabManager works with VMware and Microsoft Virtual Server, said Sameer Dholakia, CEOof VMLogix.
VMware, which dominates the market for x86 virtualization, has a similar product, also called Lab Manager, which allows enterprises to use data center resources for application development and testing. On Jan. 21, VMware added another production tool, called Stage Manager, which helps streamline the process of bringing a new application through various test phases before full deployment within a business.
The advantage of VMLogix's LabManager, Dholakia said, is that it works with multiple virtualization technologies, including VMware's products. The software controls the operating systems with the virtual machine, which helps drive automation during testing, he said.
Dholakia mirrors the argument put forth by Parallels, which is that users of virtualization technology are looking beyond the hypervisor toward better management tools to control the different virtual environments within a data center. The real value for companies is in improving the entire ecosystem and making it easier to control.
"It's now generally recognized in the industry that the hypervisor itself is becoming commoditized, and people are now beginning to look up the stack for the real value," he said.